ATE499611T1 - METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I - Google Patents
METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-IInfo
- Publication number
- ATE499611T1 ATE499611T1 AT04764908T AT04764908T ATE499611T1 AT E499611 T1 ATE499611 T1 AT E499611T1 AT 04764908 T AT04764908 T AT 04764908T AT 04764908 T AT04764908 T AT 04764908T AT E499611 T1 ATE499611 T1 AT E499611T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- diseases
- apolipoprotein
- determining
- determining apolipoprotein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
Abstract
Diagnosis, early recognition, risk assessment and monitoring progression of diseases comprising determining, in a human serum or plasma sample, the content of apolipoprotein C-I (A) and/or its derivatives, is new. Disease is deduced if the measured value is significantly different from values in a healthy subject. An independent claim is also included for use of (A) to prepare an injectable composition for treatment of cancer and sepsis. ACTIVITY : Antibacterial; Immunosuppressive; Cytostatic. No biological data given. MECHANISM OF ACTION : None given.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10343815A DE10343815A1 (en) | 2003-09-22 | 2003-09-22 | Diagnosis, particularly of cancer and sepsis, by determining abnormal contents of apolipoprotein C-I in serum or plasma, also therapeutic use of apolipoprotein C-I |
PCT/EP2004/009965 WO2005038461A1 (en) | 2003-09-22 | 2004-09-07 | Method for the diagnosis of diseases by determining apolipoprotein ci |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE499611T1 true ATE499611T1 (en) | 2011-03-15 |
Family
ID=34306015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04764908T ATE499611T1 (en) | 2003-09-22 | 2004-09-07 | METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100159492A1 (en) |
EP (1) | EP1664789B1 (en) |
JP (1) | JP2007506075A (en) |
CN (1) | CN1856707A (en) |
AT (1) | ATE499611T1 (en) |
DE (2) | DE10343815A1 (en) |
ES (1) | ES2358903T3 (en) |
WO (1) | WO2005038461A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT502227B1 (en) * | 2005-08-08 | 2007-08-15 | Vitateq Biotechnology Gmbh | METHOD FOR DIAGNOSIS OF TUMORS |
DE102006056337A1 (en) | 2006-11-29 | 2008-06-05 | B.R.A.H.M.S Ag | In vitro diagnostic and early diagnosis of neurodegenerative diseases |
JP5366234B2 (en) * | 2007-08-24 | 2013-12-11 | 学校法人関西医科大学 | Prognosis prediction method and prognosis prediction kit after radiation therapy for squamous cell carcinoma |
KR101431062B1 (en) * | 2012-03-08 | 2014-08-21 | (주)바이오메디앙 | Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same |
KR101431063B1 (en) * | 2012-03-08 | 2014-08-21 | (주)바이오메디앙 | Protein marker apolipoprotein c-1 for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same |
CN105652019B (en) * | 2016-02-22 | 2017-10-20 | 西安交通大学 | A kind of autism serum polypeptide mark APOC1 A and its application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08178923A (en) * | 1994-12-21 | 1996-07-12 | Cosmo Sogo Kenkyusho:Kk | Immunoassay of lipoprotein or apolipoprotein |
WO1997036927A1 (en) | 1996-03-29 | 1997-10-09 | Dario Boffelli | Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
WO2000055635A1 (en) * | 1999-03-16 | 2000-09-21 | Serex Inc. | Method and device for detection of apo a, apo b and the ratio thereof in saliva |
IL163732A0 (en) * | 2002-03-07 | 2005-12-18 | Univ Johns Hopkins | Genomic screen for epigenetically silenced tumor suppressor genes |
NL1020962C2 (en) * | 2002-06-28 | 2003-12-30 | Tno | Therapy and prognosis / monitoring for sepsis and septic shock. |
-
2003
- 2003-09-22 DE DE10343815A patent/DE10343815A1/en not_active Withdrawn
-
2004
- 2004-09-07 US US10/572,522 patent/US20100159492A1/en not_active Abandoned
- 2004-09-07 DE DE502004012230T patent/DE502004012230D1/en active Active
- 2004-09-07 WO PCT/EP2004/009965 patent/WO2005038461A1/en active Application Filing
- 2004-09-07 CN CNA2004800274133A patent/CN1856707A/en active Pending
- 2004-09-07 AT AT04764908T patent/ATE499611T1/en active
- 2004-09-07 JP JP2006526553A patent/JP2007506075A/en active Pending
- 2004-09-07 ES ES04764908T patent/ES2358903T3/en active Active
- 2004-09-07 EP EP04764908A patent/EP1664789B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
DE10343815A1 (en) | 2005-04-14 |
CN1856707A (en) | 2006-11-01 |
ES2358903T3 (en) | 2011-05-16 |
EP1664789B1 (en) | 2011-02-23 |
US20100159492A1 (en) | 2010-06-24 |
DE502004012230D1 (en) | 2011-04-07 |
WO2005038461A1 (en) | 2005-04-28 |
JP2007506075A (en) | 2007-03-15 |
EP1664789A1 (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2539854T3 (en) | Early diagnosis and prediction based on the detection of IL-6 of systemic inflammatory response syndrome and sepsis in asymptomatic patients | |
WO2004058044A3 (en) | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor | |
ATE469353T1 (en) | USE OF NT-PROANP AND NT-PROBNP FOR DIAGNOSING HEART DISEASE | |
ATE315789T1 (en) | ELISA FOR VEGF | |
WO2006119292A3 (en) | Methods for detection of biological substances | |
US20080131902A1 (en) | Personalized skin care composition and method for production thereof | |
MX2009003562A (en) | Elisa for vegf. | |
ATE423217T1 (en) | ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF ANALYTE COMPONENTS OF THE PLASMINOGEN ACTIVATOR SYSTEM IN SAMPLES OF BODY FLUID | |
WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
de Jesus Pereira et al. | Feelings of powerlessness in patients with diabetic foot ulcers | |
ATE432997T1 (en) | THERAPY MONITORING FOR TUMORS USING ACC133 MRNA | |
DE502006008028D1 (en) | LIQUORDIAGNOSTIC IN VITRO METHOD FOR THE DIAGNOSIS OF DEMENTIA DISEASES AND NEUROINFLAMMATORY DISEASES | |
ATE283487T1 (en) | METHOD FOR DIAGNOSIS OR PROGNOSIS OF AGE-RELATED MACULAR DEGENERATION | |
ATE441107T1 (en) | ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF THE EXTRACELLULAR DOMAIN (ECD) ANALYTE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ALONE OR IN COMBINATION WITH OTHER ANALYTES, IN BODY FLUID SAMPLES | |
ATE499611T1 (en) | METHOD FOR DIAGNOSIS OF DISEASES DETERMINING APOLIPOPROTEIN C-I | |
DE60133510D1 (en) | Automatic method for the quantitative determination and monitoring of exogenous hemoglobin in whole blood, blood plasma and blood serum | |
ATE520987T1 (en) | METHOD FOR DETECTING AND/OR SCREENING FOR MONITORING COLORECTAL CANCER IN AN INDIVIDUAL | |
ATE494556T1 (en) | METHOD FOR DIAGNOSING INFLAMMATORY DISEASES AND INFECTIONS USING LASP-1/LAP-1 DETERMINATION | |
ATE352039T1 (en) | METHOD FOR DETERMINING THYMIDINKINASE-1 ACTIVITY AND USE THEREOF | |
JP5535571B2 (en) | Method for evaluating skin turnover and its use | |
RU2538644C1 (en) | Method for prediction of acute pancreatitis progression following abdominal surgeries | |
FR2849204B1 (en) | METHOD OF DETECTING PRPSC USING AMINOGLYCOSIDE FAMILY D Antibiotics for PRPSC Removal and Detection in Biological Samples | |
AR056831A1 (en) | METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES | |
WO2003056341A3 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
RU2374986C1 (en) | Method of estimating functional state of cardio-vascular system of man |